Opioid receptors are fantastic targets for treating pain—but unfortunately, the drugs that target them can be addictive. Because the molecules suppress breathing and heart function, those drugs can ...
Eli Lilly has agreed to pay Radionetics Oncology $140m upfront to partner on the biotech’s G protein-coupled receptor (GPCR)-targeting small-molecule radiopharmaceuticals. The strategic agreement also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
